Clinical Trials Directory

Trials / Unknown

UnknownNCT02337049

Preeclampsia Subtypes and Surrogate Markers of CVD Risk

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
University of Aarhus · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

In order to assess surrogate markers of cardiovascular risk in subtypes of preeclampsia, we will conduct a 10-year follow-up study comparing 40 women with a history of early onset preeclampsia; 40 women with a history of late onset preeclampsia and 40 women with a history of normotensive pregnancies. Eligible participants delivered at the Department of Obstetrics at Randers Regional Hospital 1998-2008. Early-onset preeclampsia is defined as preeclampsia that develops before 34 weeks of gestation, whereas late-onset preeclampsia develops at or after 34 weeks of gestation.

Conditions

Timeline

Start date
2014-09-01
Primary completion
2015-12-01
Completion
2016-04-01
First posted
2015-01-13
Last updated
2015-01-13

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02337049. Inclusion in this directory is not an endorsement.

Preeclampsia Subtypes and Surrogate Markers of CVD Risk (NCT02337049) · Clinical Trials Directory